Exploring a combined biomarker for tuberculosis treatment response: protocol for a prospective observational cohort study.

Frank Kloprogge Ibrahim AbubakarHanif EsmailVanessa HackHeinke KunstTimothy D McHughMahdad NoursadeghiJulian SureySimon TiberiMarc Caeroos Isaac Lipman

Published in: BMJ open (2021)

The observational cohort study has been approved by the UK's HRA REC (20/SW/0007). Written informed consent will be obtained. Results will be disseminated via publication, presentation and through engagement with institutes/companies developing novel anti-TB treatment combinations.

Keyphrases

mycobacterium tuberculosis
randomized controlled trial
social media
cross sectional
emergency department
hiv aids
combination therapy
adverse drug
drug administration
replacement therapy
smoking cessation